Genome profiling of fluoroquinolone-resistant uropathogenic Escherichia coli isolates from Brazil.

Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]
Patrick da SilvaCristiano G Moreira

Abstract

Urinary tract infections (UTIs) are a major public health concern in both community and hospital settings worldwide. Uropathogenic Escherichia coli (UPEC) is the main causative agent of UTI and increasingly associated with antibiotic resistance. Herein, we report the draft genome sequence of 9 fluoroquinolone-resistant UPEC isolates from Brazil and examine selected major phenotypic features, such as antimicrobial resistance profile, phylogroup, serotype, sequence type (ST), virulence genes, and resistance marks. Besides the quinolone resistance, beta-lactams, ESBL production, aminoglycosides, and tetracycline resistance were observed. High prevalence of 20 virulence genes was detected in all isolates, such as those encoding type 1 fimbriae, acid tolerance system, and hemolysin E, particularly within E. coli B2 phylogroup, as ST131 and ST1193 strains, among other genomic analyses as genomic islands, resistance plasmids, and integron identification.

References

Feb 15, 2001·The Journal of Infectious Diseases·W E Stamm, S R Norrby
Mar 26, 2004·Nature Reviews. Microbiology·James B KaperHarry L Mobley
Feb 21, 2009·Bioinformatics·Alexandra MouraAntónio Correia
Aug 14, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Maria Cecilia Cergole-NovellaAntonio C C Pignatari
Oct 20, 2010·Bioinformatics·Aaron PetkauGary Van Domselaar
Nov 18, 2010·The Journal of Antimicrobial Chemotherapy·Benjamin A RogersDavid L Paterson
Dec 15, 2010·Bioinformatics·Marten BoetzerWalter Pirovano
Jul 5, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G PeiranoJ D D Pitout
Dec 14, 2011·Genome Research·Jared T Simpson, Richard Durbin
Jan 13, 2012·Journal of Clinical Microbiology·Mette V LarsenOle Lund
Oct 3, 2012·PloS One·Andrew TrittAaron E Darling
Oct 26, 2012·BMC Bioinformatics·Francesca NadalinAlberto Policriti
Jan 5, 2013·The Journal of Infectious Diseases·James R JohnsonEvgeni V Sokurenko
Feb 4, 2014·Infectious Disease Clinics of North America·Betsy Foxman
Feb 28, 2014·Journal of Clinical Microbiology·Katrine Grimstrup JoensenFrank M Aarestrup
Apr 4, 2014·Bioinformatics·Anthony M BolgerBjoern Usadel
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Nicola K PettyScott A Beatson
Sep 23, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yi-Wei HuangTsuey-Ching Yang
Nov 26, 2014·Expert Review of Anti-infective Therapy·Brian BecknellJohn David Spencer
Mar 27, 2015·Bioinformatics·Emanuele BosiMarco Fondi
May 15, 2015·Journal of Clinical Microbiology·Katrine G JoensenFlemming Scheutz
Oct 22, 2015·Annals of Clinical Microbiology and Antimicrobials·Yang DengGuangchao Yu
Mar 24, 2016·MBio·Nicole StoesserUNKNOWN Modernizing Medical Microbiology Informatics Group (MMMIG)
May 1, 2016·Nucleic Acids Research·Jean CuryEduardo Pc Rocha
Jun 28, 2016·Nucleic Acids Research·Tatiana TatusovaJames Ostell
Mar 24, 2017·Science Translational Medicine·Henry L SchreiberScott J Hultgren
Mar 28, 2017·F1000Research·Johann D D Pitout, Rebekah DeVinney
Apr 19, 2017·Journal of Global Antimicrobial Resistance·Rafaella Christina Rocha Moreira da SilvaTatiana Amabile de Campos
May 24, 2017·Antimicrobial Agents and Chemotherapy·James R JohnsonMariana Castanheira
Jun 24, 2017·Frontiers in Cellular and Infection Microbiology·Riti MannAmy L Bottomley
Jul 3, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Veronika L TchesnokovaEvgeni V Sokurenko
Oct 24, 2018·Molecular Biology and Evolution·Guangchuang YuYi Guan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.